HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

1,280.243

-44.549-3.36%

Number of Gainers:1

Number of Losers:16

Number of Flat:1

PE:- -

High:1,323.479

Open:1,323.479

Low:1,268.364

Close:1,324.792

Volume:417.34M

Turnover:3.53B

Market Cap:855.95B

Float Cap:720.78B

Loading ...

CANSINOBIO's Meningococcal Vaccine Menhycyte™ Receives Expanded Age Indication Approval

JD Health International Stock Falls 2.1% in Hong Kong

CSPC Pharmaceutical Group Stock Slips 5.2% in Hong Kong

Sino Biopharmaceutical Stock Slides 6.6% in Hong Kong, Underperforms Competitors

CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk

AH Premium Rankings for February 24th

Zhejiang Medicine to Invest in Partnership Fund Targeting Silver Economy and Healthcare Sector

Xuanzhu Biopharmaceutical to Join Hang Seng Index

MT Newswires Live

Xuanzhu Biopharmaceutical Joins Hang Seng Composite IndexXuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026

Sino Biopharmaceutical Stock Rises 1.8% in Hong Kong

Sinopharm Group Stock Slips 2.3% in Hong Kong

JD Health International Stock Slips 6.3% in Hong Kong

Hong Kong shares slip after Lunar New Year break

A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth

Simply Wall St.

Alibaba Health, JD Health Unlikely to Be Hurt by AI -- Market Talk

Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After New Obesity And Pain Drug Trial Clearances

Simply Wall St.

Sinopharm Group Co. Ltd.'s (HKG:1099) Low P/E No Reason For Excitement

Simply Wall St.

Sinopharm Group Stock Rallies 0.8% in Hong Kong

CSPC PHARMA's Long-Acting GLP-1/GIP Dual Agonist Receives FDA Clearance for US Clinical Trials

BRIEF-CSPC Pharmaceutical Obtains FDA Approval For SYH2082 Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1280.2434,"timestamp":1771920487216,"preClose":1324.792,"halted":0,"volume":417342427,"delay":0,"changeRate":-0.033627,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-44.548584,"latestTime":"02-24 16:00:00","open":1323.4788,"high":1323.4788,"low":1268.3638,"amount":3532891138,"amplitude":0.041603,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771983000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771896600000,1771905600000],[1771909200000,1771920000000]],"pbRate":2.368531,"peRate":25.127896,"turnoverRate":0.005231,"increases":1,"decrements":16,"flats":0,"marketCap":855948872832,"floatMarketCap":720777781376},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1323.4788,"amplitude":0.041603,"preClose":1324.792,"low":1268.3638,"pbRate":"2.368531","latestPrice":1280.2434,"volume":417342427,"delay":0,"open":1323.4788,"prevYearClose":1190.107,"prevWeekClose":1300.604,"prevMonthClose":1330.61,"prevQuarterClose":1190.107,"fiveDayClose":1313.866,"twentyDayClose":1345.754,"sixtyDayClose":1263.217,"secType":"PLATE","market":"HK","turnoverRate":0.005231,"peRate":25.127896,"marketCap":855948872832,"floatMarketCap":720777781376,"timestamp":1771920487216,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":1,"down":16,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1159534204","title":"CANSINOBIO's Meningococcal Vaccine Menhycyte™ Receives Expanded Age Indication Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1159534204","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159534204?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:46","pubTimestamp":1771922808,"startTime":"0","endTime":"0","summary":"CANSINOBIO (06185) announced that it has received a Supplemental Drug Application Approval Notice from the National Medical Products Administration (NMPA). According to the notice, the NMPA has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","BK1574","BK1515","06185"],"gpt_icon":0},{"id":"2613943795","title":"JD Health International Stock Falls 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2613943795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613943795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:33","pubTimestamp":1771921980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slid 2.1% to 56.90 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.JD Health International Inc. closed 21% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 7.7 million shares, compared to the 50-day average of 7.4 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4558","BK1615","LU0326950275.SGD","IE00BGV7N243.SGD","BK1571","HK0000306685.HKD","KJD","SGXZ86797644.SGD","IE0008368742.USD","BK4614","BK4220","BK4505","BK4526","HK0000320223.HKD","LU0588546209.SGD","LU0463099449.HKD","BK4509","BK4504","06618","SGXZ62798434.SGD","LU0307460666.USD","BK1591","86618","BK4122","BK4503","LU0456827905.SGD","HK0000306701.USD","LU1688375341.USD","LU0106959298.USD","HK0000320264.USD","BK4588","LU0051755006.USD","BK1515","BK4579","BK1589","BK1247","BK4524","BK4551","BK1142","BK4531","BK1583","LU0244354667.USD","LU1880383366.USD","BK4585","LU1188198961.HKD","SG9999002463.SGD"],"gpt_icon":1},{"id":"2613687795","title":"CSPC Pharmaceutical Group Stock Slips 5.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2613687795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613687795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:31","pubTimestamp":1771921860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 5.2% to 10.06 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.The stock's fall snapped a three-day winning streak.CSPC Pharmaceutical Group Ltd. closed 13% below its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 6.6%, SSY Group Ltd. rose 0.3%, and United Laboratories International Holdings Ltd. fell 3.3%.Trading volume totaled 102.2 million shares, compared to the 50-day average of 127.4 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE0008369823.USD","LU0067412154.USD","HK0000165453.HKD","LU1008478684.HKD","LU0072913022.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1226288253.USD","LU0326950275.SGD","01093","SG9999004220.SGD","IE00B543WZ88.USD","LU1993786604.SGD","LU0880133367.SGD","IE0008368742.USD","LU0140636845.USD","LU1813983027.USD","LU0501845795.SGD","BK1191","LU1951186391.HKD","LU0314109678.HKD","BK1515","IE00BZ08YR35.GBP","LU1226287529.USD","LU2039709279.SGD","BK1521","LU1226287792.SGD","LU1226287875.USD","LU0315179316.USD","LU1152091754.HKD","LU1152091168.USD","LU1226288170.HKD","LU1960683339.HKD","IE00B031HY20.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2613572795","title":"Sino Biopharmaceutical Stock Slides 6.6% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613572795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613572795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:31","pubTimestamp":1771921860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 6.6% to 6.39 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.The stock's fall snapped a three-day winning streak.Sino Biopharmaceutical Ltd. closed 30% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 5.2% and Amgen Inc. remained unchanged.Trading volume totaled 91.3 million shares, compared to the 50-day average of 62.2 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","HK0000165453.HKD","BK1521","BK1515","IE00BZ08YS42.EUR","01177","IE00BZ08YR35.GBP","BK1191","BK1589"],"gpt_icon":0},{"id":"2613793067","title":"CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793067","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613793067?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:25","pubTimestamp":1771921500,"startTime":"0","endTime":"0","summary":"0825 GMT - The size of CSPC Pharmaceutical's deal struck with AstraZeneca last month beat CGS International's expectations and implies the Chinese company's drug pipeline is undervalued, analyst Vicky Zhu says. She notes that the pharmaceutical company has around 90 innovative drugs in its pipeline at various clinical stages. CSPC's revenue is expected to recover from 2026, as the drag from volume-based procurement price cuts is likely to have been digested in 2025, Zhu adds in a note. CGSI raises its target price to HK$11.63 from HK$11.12 and retains an add rating on CSPC Pharma, which ends 5.2% lower at HK$10.06. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU1226287529.USD","BK1515","LU1993786604.SGD","LU1152091754.HKD","LU0501845795.SGD","LU0067412154.USD","LU0880133367.SGD","LU0314109678.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226287792.SGD","IE0008369823.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU0140636845.USD","LU1152091168.USD","LU1807302812.USD","LU1226287875.USD","LU1226288253.USD","BK1191","IE0008368742.USD","IE00B031HY20.USD","LU1008478684.HKD","01093","SG9999004220.SGD","IE00BZ08YS42.EUR","LU1951186391.HKD","IE00B5MMRT66.SGD","LU1813983027.USD","BK1521","IE00BZ08YT58.USD","LU0326950275.SGD","LU1960683339.HKD","LU2039709279.SGD","LU0315179316.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"1179077937","title":"AH Premium Rankings for February 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=1179077937","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179077937?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:21","pubTimestamp":1771921291,"startTime":"0","endTime":"0","summary":"As of the market close on February 24th, NE ELECTRIC (00042), JINGCHENG MAC (00187), and Sinopec Oilfield Service (01033) recorded the highest AH share premium rates, at 757.14%, 285.62%, and 282.18%...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1105","HK0000352382.USD","LU0348788117.USD","LU0043850808.USD","LU1211504680.USD","LU0516423174.USD","LU0531970944.HKD","LU0348827113.USD","LU0502904849.HKD","LU1282649810.SGD","BK1552","LU1152091168.USD","IE0031814852.USD","LU1008478684.HKD","BK1515","LU0163747925.USD","LU2153592121.USD","LU0266512473.USD","LU0823039010.USD","IE00BVYPNQ40.USD","SG9999002463.SGD","LU0819121731.USD","BK1543","LU0588545730.USD","LU0572940350.SGD","IE00B0169L03.USD","LU0469268626.HKD","LU0634319403.HKD","LU0181495838.USD","LU0143863784.USD","IE00B3M56506.USD","HK0000306685.HKD","BK1231","BK1562","LU2399975544.HKD","00042","BK1140","LU0456827905.SGD","IE00BYV24P56.USD","IE00B031HY20.USD","LU1880383366.USD","LU0289960550.SGD","LU0821914370.USD","LU0096374516.USD","LU0084288322.USD","LU0329678170.USD","002594","BK1229","LU0164865239.USD","LU2476274720.SGD","LU0320764599.SGD","LU2097828714.EUR","BK1191","LU1868838027.USD","LU0823426308.USD","IE00BZ08YT58.USD","81211","LU0214875030.USD","LU0865486749.SGD","LU0269904917.USD","BK1550","LU0348735423.USD","LU0039217434.USD","LU0266512127.USD","LU0370786039.SGD","LU0594300179.USD","LU0856984785.SGD","LU0880133367.SGD","LU2360107325.USD","LU1769817179.HKD","LU2039709279.SGD","LU0164880469.USD","LU1880383440.USD","399300","BYDDY","LU2097828474.EUR","HYDD.SI","LU0511384066.AUD","SG9999014674.SGD","LU1960683339.HKD","HK0000306701.USD","BK1592","LU0359201612.USD","LU0516422440.USD","LU2778985437.USD","LU0149721374.USD","LU0594300419.USD","SG9999006514.SGD","LU0979878070.USD","LU0229945570.USD","LU1188198961.HKD","LU0620787316.HKD","LU0164939612.USD","BK1537","LU0456854461.SGD","LU0455707207.USD","LU1328277881.USD","LU0488056044.USD","LU0417516571.SGD","LU0348783233.USD","LU0868486357.SGD","BK1223","BK1183","LU0543330566.HKD","SG9999002828.SGD","LU0456846285.SGD","LU0737861772.HKD","LU0211977185.USD","IE00BZ08YR35.GBP","LU0254981946.USD","IE00BF5LJ272.USD","BK1237","BK1563","LU0708995583.HKD","LU0231483743.USD","BK1540","LU0588546209.SGD","LU0791591158.USD","BK1184","LU0051755006.USD","BK1507","LU0106959298.USD","LU1224709979.USD","LU0828238088.HKD","00187","LU0886674414.USD","LU2097828557.USD","LU0431992006.USD","LU0328353924.USD","BK1528","BK1174","LU1366334651.USD","LU0259732245.USD","LU0359201885.HKD","BK1163","LU0244354667.USD","BK1202","LU0505663152.USD","BK1224","LU0052750758.USD","IE0034224299.USD","LU1808992512.USD","LU0540923850.HKD","LU0588545904.SGD","LU2125910500.SGD","LU1720050803.USD","LU0048580855.USD","BK1198","LU0890818403.SGD","LU0348825331.USD","LU0348784397.USD","LU0823414478.USD","LU2097828631.EUR","LU0359202008.SGD","LU0509642566.USD","HK0000320223.HKD","BK1171","BK1583","LU1868837565.USD","LU0516422366.SGD","LU1105468828.SGD","LU0791590937.USD","BK1522","LU2506951792.HKD","LU0326950275.SGD","IE00B031J352.USD","LU0593848301.USD","LU0165289439.USD","LU0314109678.HKD","IE00B543WZ88.USD","LU0327786744.USD","BK1576","LU0918141887.USD","LU0264606111.USD","LU0287142896.SGD","LU0737861699.HKD","BK1214","LU0516423091.SGD","LU1675838814.USD","LU1961090484.USD","LU2357125470.USD","LU0067412154.USD","LU2045819591.USD","LU1719994722.HKD","LU0329678337.USD","LU0823414551.USD","LU0307460666.USD","LU1794554557.SGD","159982","BK1112","LU0417516902.SGD","LU1366334578.USD","BK1521","LU0828237940.HKD","BK1560","LU0640798160.USD","LU0449509016.USD","LU1048596156.SGD","LU1251922891.USD","LU0561508036.HKD","LU0650527681.SGD","LU0315178854.USD","IE00BPRC5H50.USD","BK1610","LU1831875114.USD","BK1546","IE0008369823.USD","LU0589944569.HKD","LU0228367735.SGD","LU1813983027.USD","LU0516422952.EUR","BK1135","LU1303224171.USD","BK1594","LU0082770016.SGD","LU0572944931.SGD","03143","BK1582","LU3063872942.SGD","IE00BD6J9T35.USD","LU0117841782.USD","LU0871576103.HKD","LU0449515922.USD","LU0348805143.USD","BK1564","LU0588545490.SGD","LU0823426480.USD","LU0164872284.USD","LU0345780521.USD","LU1226287529.USD","HK0000320264.USD","LU2348774022.SGD","LU1861219969.SGD","LU0049853897.USD","IE00BVYPNP33.GBP","LU0572939691.SGD","BK1554","LU1242518931.SGD","LU0348816934.USD","LU0072913022.USD","LU1770034418.SGD","BK1509","LU1993786604.SGD","LU2449936058.SGD","SG9999015986.USD","BK1149","BK1551","BK1205","BK1544","LU1688375341.USD","LU0648948544.HKD","BK1258","LU0828237510.HKD","LU0862451753.SGD","600860","LU1481107354.HKD","LU0061477393.USD","SG9999001226.SGD","LU1152091754.HKD","LU2249611893.SGD","IE00BGHQDM52.EUR","SG9999004220.SGD","IE00B29SXG58.USD","LU0501845795.SGD","LU0082770016.USD","BK1584","LU1504937902.USD","SG9999015978.USD","BK1503","LU0823038988.USD","LU1282649067.USD","BK1574","LU1807302812.USD","LU2294711713.HKD","LU0228659784.USD","IE0008368742.USD","LU0143863198.USD","BK1119","SG9999015945.SGD","BK1161","LU0054450605.USD","LU0531971595.HKD","IE00BZ08YS42.EUR","LU1282648689.USD","LU1023057109.AUD","LU1769817096.USD","LU0140636845.USD","LU0175139822.USD","LU0797268264.HKD","LU0463099449.HKD","LU0605514214.HKD","LU1046422090.SGD","LU1115378108.SGD","LU1868837722.USD","LU0289739343.SGD","BK1147","LU0289961442.SGD","BK1116","LU0345780281.USD","BK1501","LU2097828805.USD","LU2226246903.HKD","IE00BMCWC346.EUR","IE00B5MMRT66.SGD","LU2476274308.USD","BK1505","LU1282649141.HKD","LU1242518857.USD","LU0819123356.HKD","LU0417516738.SGD","BK1514","LU0384037296.USD","LU0348814723.USD","LU0315179316.USD","HK0000352291.HKD","BK1539","LU2242644610.SGD","LU0106252389.USD","SG9999015952.SGD","BK1240","LU0173614495.USD","SG9999006597.SGD","LU1861214812.USD","LU0918141705.HKD","BK1141"],"gpt_icon":0},{"id":"1152132520","title":"Zhejiang Medicine to Invest in Partnership Fund Targeting Silver Economy and Healthcare Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1152132520","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152132520?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:57","pubTimestamp":1771919826,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co.,Ltd. (600216.SH) announced that on February 24, 2026, the company signed a partnership agreement with general partner CITIC Healthcare Equity Investment Private Fund Management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK0028","BK1515","BK0239","09939","600216","BK0188","BK0191","BK1574","BK1161"],"gpt_icon":0},{"id":"2613083972","title":"Xuanzhu Biopharmaceutical to Join Hang Seng Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2613083972","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613083972?lang=en_us&edition=fundamental","pubTime":"2026-02-23 10:01","pubTimestamp":1771812091,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group  said its non-wholly owned subsidiary Xuanzhu Biopharmaceutical  is due for inclusion to the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.Xuanzhu Biopharmaceutical went public in Hong Kong in October of last year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","BK1515","00460","02575","BK1600","BK1191"],"gpt_icon":0},{"id":"2613222177","title":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index**Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2613222177","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613222177?lang=en_us&edition=fundamental","pubTime":"2026-02-22 18:06","pubTimestamp":1771754767,"startTime":"0","endTime":"0","summary":"**Xuanzhu Biopharmaceutical Joins Hang Seng Composite Index** Xuanzhu Biopharmaceutical Co., Ltd. said it will be included as a constituent stock of the Hang Seng Composite Index following Hang Seng Indexes’ quarterly review, with the change taking effect on March 9, 2026. Xuanzhu Biopharmaceutical Co., Ltd. said it will be **added** as a constituent stock of the **Hang Seng Composite Index** following the Hang Seng Indexes Company’s quarterly review for the period ended Dec. 31, 2025, with the change effective March 9, 2026. The company said the inclusion reflects investor recognition of its value and growth potential and is expected to improve share liquidity and broaden its investor base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260222:nNDL2nmBT7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02575","BK1191","BK1593","BK1600","00460"],"gpt_icon":0},{"id":"2612250906","title":"Sino Biopharmaceutical Stock Rises 1.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2612250906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612250906?lang=en_us&edition=fundamental","pubTime":"2026-02-20 16:32","pubTimestamp":1771576320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 1.8% to 6.65 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 26413.35.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 27% short of its 52-week high of HK$9.12, which the company reached Sept. 10.The stock demonstrated a mixed performance when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.6% and Amgen Inc. remained unchanged.Trading volume totaled 21.0 million shares, compared to the 50-day average of 62.8 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","IE00BZ08YT58.USD","BK1589","IE00BZ08YR35.GBP","BK1191","BK1515","IE00BZ08YS42.EUR","HK0000165453.HKD","01177"],"gpt_icon":0},{"id":"2612132250","title":"Sinopharm Group  Stock Slips 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2612132250","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612132250?lang=en_us&edition=fundamental","pubTime":"2026-02-20 16:32","pubTimestamp":1771576320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.3% to 20.98 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 26413.35.The stock's fall snapped a three-day winning streak.Sinopharm Group Co. Ltd. closed 3.1% short of its 52-week high of HK$21.66, which the company reached Nov. 14.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 2.3%.Trading volume totaled 4.8 million shares, compared to the 50-day average of 4.8 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1500","BK1197","LU1115378108.SGD","SHTDY","01099","BK1515","BK4175"],"gpt_icon":0},{"id":"2612250970","title":"JD Health International Stock Slips 6.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2612250970","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612250970?lang=en_us&edition=fundamental","pubTime":"2026-02-20 16:30","pubTimestamp":1771576200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slid 6.3% to 56.85 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.1% to 26413.35.The stock's fall snapped a two-day winning streak.JD Health International Inc. closed 21% short of its 52-week high of HK$71.70, which the company reached Jan. 15.Trading volume totaled 5.9 million shares, compared to the 50-day average of 7.5 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","BK4505","BK4585","KJD","BK4524","BK1589","BK1142","LU0588546209.SGD","BK1583","SG9999002463.SGD","BK1615","LU0463099449.HKD","LU0106959298.USD","BK1591","06618","LU1688375341.USD","BK4531","BK4558","LU0244354667.USD","BK4551","BK4503","HK0000306685.HKD","BK4526","HK0000320223.HKD","SGXZ86797644.SGD","BK4579","LU0307460666.USD","LU0051755006.USD","BK4122","HK0000306701.USD","BK4220","BK4504","BK4614","BK4509","LU1880383366.USD","IE0008368742.USD","LU1188198961.HKD","LU0326950275.SGD","BK4588","BK1247","BK1515","86618","LU0456827905.SGD","SGXZ62798434.SGD","HK0000320264.USD","IE00BGV7N243.SGD"],"gpt_icon":1},{"id":"2612256225","title":"Hong Kong shares slip after Lunar New Year break","url":"https://stock-news.laohu8.com/highlight/detail?id=2612256225","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612256225?lang=en_us&edition=fundamental","pubTime":"2026-02-20 13:03","pubTimestamp":1771563782,"startTime":"0","endTime":"0","summary":"Hong Kong shares slip after Lunar New Year break HONG KONG, Feb 20 (Reuters) - Hong Kong shares slipped on Friday as the local market reopened after the three-day Lunar New Year break, with technology","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL1N3ZG04M:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0327786744.USD","BK1571","IE00BFMHRM44.USD","BK0164","LU0650527681.SGD","LU0287142896.SGD","LU0211977185.USD","LU0640798160.USD","LU0797268264.HKD","LU0949170772.SGD","LU0359202008.SGD","LU0345776255.USD","LU0553294199.USD","LU1481107354.HKD","LU0348805143.USD","LU0918141887.USD","LU0499858438.USD","LU2039709279.SGD","LU0328353924.USD","LU0543330483.HKD","LU0594300419.USD","LU0708995583.HKD","KBAB","LU0072913022.USD","BK4122","BK4504","LU1719994722.HKD","06618","BK4554","LU0251143458.SGD","LU0417516902.SGD","LU1235294995.USD","LU1303224171.USD","BK4543","BK0187","600938","00857","BK4526","BK4535","LU0106959298.USD","LU0359201885.HKD","BK4514","LU0417516738.SGD","LU2580892789.USD","LU0348814723.USD","BK1515","BK1589","BK1100","LU1282651048.USD","BK4527","LU0048580855.USD","BK0070","LU0051755006.USD","LU0293314216.USD","LU0588545490.SGD","LU1267930227.SGD","LU0651946864.USD","LU2148510915.USD","BK0183","BK0000","LU0501845795.SGD","BK1585","BK0028","LU1046422090.SGD","LU0128522157.USD","SG9999001226.SGD","LU1688375341.USD","SGXZ62798434.SGD","BK4552","BK1502","LU0052756011.USD","LU1251922891.USD","LU1880383366.USD","BK4607","LU0791590937.USD","LU0880133367.SGD","LU1105468828.SGD","LU1997244956.HKD","LU1580142542.USD","LU1051768304.USD","LU1515016050.SGD","BK1619","LU0173614495.USD","BK4602","LU0384037296.USD","KBDU","LU0140636845.USD","LU2226246903.HKD","BABW","LU1152091754.HKD","SG9999002828.SGD","LU0310800965.SGD","LU0672654166.SGD","LU1008478684.HKD","LU1044876610.USD","86618","BIDG","LU1770036033.HKD","SGXZ49509284.SGD","LU0228659784.USD","LU1328615791.USD","BK1247","BK4581","LU0307460666.USD","LU0469268626.HKD","LU2298064838.USD","IE00B0JY6N72.USD","BK4503","BK4533","LU2242644610.SGD","LU1366334578.USD","BK4574","LU0572944931.SGD","BK1142","601857","LU1064130708.USD","BK1610","BK1588","LU1242518931.SGD","LU1044875133.USD","LU0821914370.USD","LU0918141705.HKD","LU1282651121.HKD","BK0006","LU1813983027.USD","LU0348816934.USD","LU1282649810.SGD","LU1242518857.USD","LU0228367735.SGD","BK4524","LU1003077747.HKD","89618","BK0196","BK4612","LU0052750758.USD","LU0320764755.SGD","LU2495084118.USD","LU1044874839.SGD","LU2148611432.USD","ALBmain","LU0315179316.USD","BK1617","LU0359201612.USD","BABU","BK4585","LU0651947912.USD","LU1969619763.USD","BK4587","LU0588546209.SGD","BK4614","LU0588545730.USD","SG9999002562.SGD","LU1051769294.HKD","BK4502","LU1282649067.USD","02025","LU2328871848.SGD","LU1934453819.USD","LU0072462343.USD","LU0084288322.USD","LU1046421795.USD","LU1794554557.SGD","LU0738911758.USD","LU0345775950.USD","LU1152091168.USD","LU1823568750.SGD","LU0531971595.HKD","LU0314109678.HKD","LU0456846285.SGD","SGXZ81163826.USD","LU0348735423.USD","BK4588","BK4558","BK0188","LU0456842615.SGD","LU1769817096.USD","BK4505","LU1224444064.USD","LU1328277881.USD","LU0231483743.USD","LU1366334651.USD","LU0868486357.SGD","LU1282648689.USD","LU1770034418.SGD","LU2289578879.USD","LU1023057109.AUD","LU1997245094.SGD","BK1249","LU0259732245.USD","BK0176","LU0029875118.USD","LU1808992512.USD","BK4220","LU0431992006.USD","LU0828237510.HKD","BK1575","LU1048596156.SGD","BK4538","00883","LU0661504455.SGD","BK0076","LU0320764599.SGD","LU0163747925.USD","BK0197","LU0370786039.SGD","LU0456827905.SGD","BBYY","IE00BF5LJ272.USD","LU1997245177.USD","LU0149721374.USD","LU1048588211.SGD","LU2257852520.SGD","LU2580892862.HKD","LU1115378108.SGD","BABO","BK1583","LU1720050803.USD","BK4077","LU0791591158.USD","BK4548","LU0164880469.USD","00616","BK4534","LU0499858602.USD","BABX","BK4575","IE00B3M56506.USD","LU0871576103.HKD","02252","LU0348825331.USD","BK1591","LU0865486749.SGD","BK0201","BK0010","BK4531","LU1781817850.SGD","LU1939255532.USD","LU0047713382.USD","LU1979443071.USD","LU0315178854.USD","IE00BGV7N243.SGD","LU0164865239.USD","BK1615","IE00B29SXG58.USD","LU1064131003.USD","LU0588545904.SGD","LU0067412154.USD","LU0545039389.USD","LU0979878070.USD","LU1642822792.SGD","BK4565","BK0274","LU0128525689.USD","BK4579","BK0012","LU1769817179.HKD","LU2238339852.HKD","IE0032431581.USD","BK0259","SGXZ86797644.SGD","LU0488056044.USD"],"gpt_icon":1},{"id":"2612405689","title":"A Look At Sihuan Pharmaceutical Holdings Group (SEHK:460) Valuation After New Earnings Guidance And Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2612405689","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612405689?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:42","pubTimestamp":1771486935,"startTime":"0","endTime":"0","summary":"Guidance-driven spotlight on Sihuan Pharmaceutical Holdings Group\nSihuan Pharmaceutical Holdings Group (SEHK:460) caught investor attention after issuing unaudited 2025 earnings guidance, indicating at least RMB 2,500 million in revenue and RMB 150 million in net profit for the year.\nSee our latest analysis for Sihuan Pharmaceutical Holdings Group.\nThe earnings guidance lands after a strong run in the share price, with a 30 day share price return of 25.19% and a year to date gain of 28.12%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/a-look-at-sihuan-pharmaceutical-holdings-group-sehk460-valua","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","00460","BK1515","BK1600","BK1593"],"gpt_icon":0},{"id":"2612247203","title":"Alibaba Health, JD Health Unlikely to Be Hurt by AI -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2612247203","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612247203?lang=en_us&edition=fundamental","pubTime":"2026-02-19 14:39","pubTimestamp":1771483140,"startTime":"0","endTime":"0","summary":"0639 GMT - Alibaba Health Information Technology's and JD Health's software-as-a-service businesses aren't likely to be hurt by artificial intelligence, says Morningstar's Kai Wang in a note. Both stocks have lost around 10% in market valuation since news of AI possibly supplanting traditional software and services, the analyst says. While both companies offer software-as-a-service such as telemedicine, licensed doctors are still required to make diagnoses for patient queries, he says. \"We believe investors are conflating risks to software with health platforms and that AI can eventually perform the same tasks as diagnosing illnesses,\" he says. \"We don't see this occurring from a regulatory perspective, as an incorrect diagnosis would significantly erode public trust in a nascent industry.\" ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210526637.USD","LU1770034418.SGD","LU0545039389.USD","LU0348827113.USD","LU0328353924.USD","BK4543","LU0823040885.USD","BK1583","LU2778985437.USD","LU1720051017.SGD","LU0214875030.USD","LU0561508036.HKD","LU0359201885.HKD","HK0000320264.USD","LU0918141887.USD","LU3063872942.SGD","LU0499858602.USD","BK1618","LU0106259558.USD","00241","HK0000306701.USD","LU0823397285.USD","LU0169518387.USD","LU0449515922.USD","LU0593848301.USD","LU1770036033.HKD","ALBmain","LU0819121731.USD","LU0594300419.USD","LU0431992006.USD","LU0819123356.HKD","LU1196710864.SGD","LU1282648689.USD","LU1048484197.HKD","LU0315178854.USD","LU0128522157.USD","LU0553294199.USD","LU0823041008.USD","BK1249","LU0047713382.USD","BK4509","LU1880383440.USD","LU0128522744.USD","BK4526","BK1586","SG9999014674.SGD","LU0345775950.USD","LU0540923850.HKD","LU0029875118.USD","LU0384037296.USD","LU1188198961.HKD","BK1501","LU0607220059.USD","BK1247","LU1568876251.USD","LU1008478684.HKD","LU0049853897.USD","SG9999002562.SGD","BK4122","LU0611395673.USD","BK1610","LU1868838027.USD","SG9999001051.SGD","LU0054237671.USD","LU0231483743.USD","LU1880398471.USD","LU0577902371.SGD","LU0577902611.USD","LU0762542818.HKD","IE00B3M56506.USD","BK4588","LU1046422090.SGD","LU1282649067.USD","IE0008368742.USD","LU0130103400.USD","LU1642822792.SGD","LU1201861165.SGD","VGT","LU1242518857.USD","LU1282651048.USD","LU0029874905.USD","BK4558","LU0327786744.USD","LU0865486749.SGD","LU1323998911.USD","SG9999002828.SGD","LU0054450605.USD","LU1807302812.USD","LU0823038988.USD","LU2039709279.SGD","LU1439103000.SGD","LU0164880469.USD","LU0856984785.SGD","LU1515016050.SGD","LU0791590937.USD","LU0456846285.SGD","LU0762540952.USD","LU0572940350.SGD","LU0886674414.USD","BK1591","LU0140636845.USD","LU0128525689.USD","SG9999000327.SGD","LU1115378108.SGD","LU0173614495.USD","LU0823426308.USD","LU0608807946.USD","LU1868837565.USD","06618","LU1720050803.USD","IE00BF5LJ272.USD","LU0310800965.SGD","LU1051769294.HKD","BK4587","LU2097828805.USD","LU0862451837.USD","BK1189","LU0048597586.USD","LU0084288322.USD","LU1023057109.AUD","LU1481107354.HKD","LU1823568750.SGD","LU0640798160.USD","BK1502","LU0164865239.USD","IE00B0169N27.USD","IE00BZ08YT58.USD","LU1568876335.HKD","LU0051755006.USD","LU0630378429.USD","LU0594300179.USD","LU0823413660.USD","LU0516422952.EUR","LU0675040207.SGD","LU0531970944.HKD","BBYY","LU0359201612.USD","BK4503","LU0488056044.USD","LU0264606111.USD","LU0880133367.SGD","LU0648000940.SGD","LU0228659784.USD","LU0043850808.USD","BK4504","BK4505","SG9999004220.SGD","LU0228367735.SGD","LU0348816934.USD","LU1504937902.USD","LU2488822045.USD","LU2125910849.SGD","LU0588545730.USD","LU0918141705.HKD","LU0862451753.SGD","LU1688375341.USD","LU2257852520.SGD","LU0048580855.USD","LU0117841782.USD","LU0791591158.USD","LU1303224171.USD","LU0261950983.USD","LU0417516902.SGD","LU0868486357.SGD","LU0348783233.USD","LU0608807433.USD","LU0067412154.USD","LU0052750758.USD","LU0642271901.SGD","LU0700851271.USD","LU0229945570.USD","LU0501845795.SGD","LU1282651121.HKD","LU0572939691.SGD","LU0052756011.USD","LU0370786039.SGD","LU0708995153.HKD","LU0502904849.HKD","LU0737861772.HKD","LU0708995583.HKD","LU0823413587.USD","LU2357305700.SGD","LU0516422440.USD","LU0762541174.USD","LU0541501648.USD","LU0048388663.USD","LU1831875114.USD","LU0143863198.USD","LU0130518102.USD","LU1655091459.SGD","BK4538","LU0261947096.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1051768304.USD","LU0143863784.USD","SG9999001903.USD","LU2125910500.SGD","LU1808992512.USD","BK4581","LU0348783662.USD","LU0345776255.USD","LU0287142896.SGD","SG9999001689.USD","HBBD.SI","BK1142","LU0441854154.USD","LU0456827905.SGD","LU0132412106.USD","LU0979878070.USD","LU1810669033.SGD","BK4554","LU0516423091.SGD","LU1366334651.USD","LU2097828631.EUR","LU1720051108.HKD","BK4548","LU0254981946.USD","LU1224709979.USD","LU1769817096.USD","LU0293314216.USD","LU1211504680.USD","LU0651947912.USD","LU1003077747.HKD","BK1517","LU0516422366.SGD","IE00BZ08YS42.EUR","LU0197773673.USD","BK4575","HK0000306685.HKD","BK4220","LU0163747925.USD","BK4527","LU0588545490.SGD","86618","IE00BGV7N243.SGD","LU0477156797.USD","LU2226246903.HKD","LU1046421795.USD","LU0823397103.USD","89988","LU2097828474.EUR","IE00B543WZ88.USD","BK1615","LU0348788117.USD","LU1993786604.SGD","LU0577902298.EUR","LU1813983027.USD","LU1880398554.USD","LU1328615791.USD","BK4534","BK1589","LU2242644610.SGD","LU0096374516.USD","LU0196878994.USD","BK1617","LU0797268264.HKD","LU0738911758.USD","LU0165289439.USD","LU0072913022.USD","LU0648948544.HKD","LU0455707207.USD","LU2087589342.USD","IE00BFMHRM44.USD","LU0359202008.SGD","LU1044874839.SGD","LU0572944931.SGD","BK1571","LU0898667661.SGD","BK4585","LU0449509016.USD","BK4551","LU2097829019.USD","LU0516423174.USD","LU1152091168.USD","IE00B0JY6N72.USD","LU1960683339.HKD","LU0456842615.SGD","LU0871576103.HKD","LU1048596156.SGD","LU1251922891.USD","LU0244354667.USD","LU0661504455.SGD","LU0737861699.HKD","BK4579","IE00BZ08YR35.GBP","LU2148611432.USD","LU1048588211.SGD","SG9999000459.SGD","LU1880383366.USD","SGXZ86797644.SGD","LU0251143458.SGD","LU0630378692.HKD","LU2476274720.SGD","BK1584","LU0197773160.USD","LU0329678337.USD","BK4614","BABW","SG9999002463.SGD","IE0032431581.USD","IE0034224299.USD","LU0589944569.HKD","SGXZ62798434.SGD","LU0949170772.SGD","LU1105468828.SGD","LU1316542783.SGD","LU0259732245.USD","LU0823426480.USD","IE00BMPRXR70.SGD","LU0821914370.USD","LU0320764755.SGD","LU0588545904.SGD","LU0011963245.USD","LU0251144936.SGD","LU1956131251.USD","LU2449936058.SGD","LU0149721374.USD","LU0320764243.SGD","LU0873338254.USD","LU0469268626.HKD","LU0650527681.SGD","LU0211977185.USD","LU0828237940.HKD","LU2476274308.USD","LU0348814723.USD","LU1719994722.HKD","KBAB","LU0823039010.USD","LU0235996351.USD","LU0396098781.USD","LU1548497426.USD","SG9999001226.SGD","LU1044876610.USD","LU0348735423.USD","LU0127658192.USD","LU0543330483.HKD","LU0672654166.SGD","LU0320764599.SGD","LU0417516571.SGD","LU1282649141.HKD","IE00BMPRXN33.USD","LU0577902454.USD","LU0577902538.SGD","LU0605514214.HKD","LU0831103253.SGD","LU2097828714.EUR","LU0541502299.USD","LU0463099449.HKD","LU0315179316.USD","LU0588546209.SGD","LU0106252389.USD","SG9999006514.SGD","LU1267930227.SGD","SG9999001093.SGD","LU2152927971.USD","LU1366334578.USD","LU0543330566.HKD","BK4607","LU0784639295.USD","LU0831093199.SGD","SGXZ90724238.SGD","LU1328277881.USD","LU1794554557.SGD","LU0117844026.USD","LU0348805143.USD","LU0828237510.HKD","LU0348825331.USD","LU0651946864.USD","LU1961090484.USD","LU0329678170.USD","BABO","BK4524","LU1981816686.USD","LU1242518931.SGD","LU1282649810.SGD","LU1152091754.HKD","LU0531971595.HKD","BK1521","BK1575","LU2293587155.HKD","LU0072462343.USD","IE0003895053.USD","HK0000320223.HKD","BK1608","LU0210527791.USD","LU2097828557.USD","LU0314109678.HKD","BABX","LU0106959298.USD","LU0326950275.SGD","LU0634319403.HKD","LU0348784397.USD","IE0008368304.USD","BK4533","LU0890818403.SGD","LU0181495838.USD","BK4531","BK1588","BK4565","LU1224444064.USD","LU0061477393.USD","LU0307460666.USD","LU2399975544.HKD","SG9999006597.SGD","LU0039217434.USD","BK4502","BK4535","LU1235294995.USD","LU1769817179.HKD","LU0499858438.USD","BK1515","LU0149534421.HKD","LU1044875133.USD","LU2045819591.USD","LU0164872284.USD","LU0417516738.SGD"],"gpt_icon":1},{"id":"2612413420","title":"Assessing CSPC Pharmaceutical Group (SEHK:1093) Valuation After New Obesity And Pain Drug Trial Clearances","url":"https://stock-news.laohu8.com/highlight/detail?id=2612413420","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612413420?lang=en_us&edition=fundamental","pubTime":"2026-02-18 10:22","pubTimestamp":1771381349,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (SEHK:1093) has drawn fresh attention after securing regulatory clearance to begin clinical trials for two long acting drug candidates targeting obesity, weight related conditions, and post operative pain.\nSee our latest analysis for CSPC Pharmaceutical Group.\nThe recent regulatory clearances arrive after a strong run, with CSPC Pharmaceutical Group’s 90 day share price return of 35.40% and 1 year total shareholder return of 118.26% pointing to building momentum...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/assessing-cspc-pharmaceutical-group-sehk1093-valuation-after-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/assessing-cspc-pharmaceutical-group-sehk1093-valuation-after-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000165453.HKD","LU1226287792.SGD","LU0880133367.SGD","SG9999004220.SGD","BK1191","LU1226288253.USD","LU1226288170.HKD","LU0326950275.SGD","LU1993786604.SGD","LU0067412154.USD","LU0140636845.USD","LU0501845795.SGD","01093","LU1152091168.USD","LU1226287875.USD","IE00BZ08YS42.EUR","IE0008368742.USD","LU0072913022.USD","BK1521","IE00BZ08YR35.GBP","LU1951186391.HKD","IE00BZ08YT58.USD","LU0314109678.HKD","LU1813983027.USD","IE00B5MMRT66.SGD","LU1960683339.HKD","IE00B031HY20.USD","LU1807302812.USD","LU0315179316.USD","DCF","LU1008478684.HKD","BK1515","IE0008369823.USD","LU1152091754.HKD","LU2039709279.SGD","IE00B543WZ88.USD","LU1226287529.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"2612435592","title":"Sinopharm Group Co. Ltd.'s (HKG:1099) Low P/E No Reason For Excitement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612435592","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612435592?lang=en_us&edition=fundamental","pubTime":"2026-02-17 06:20","pubTimestamp":1771280450,"startTime":"0","endTime":"0","summary":"With a price-to-earnings (or \"P/E\") ratio of 8.4x Sinopharm Group Co. Ltd. ( HKG:1099 ) may be sending bullish signals...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-co-ltds-hkg1099-low-pe-no-reason-for-excitem","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/sinopharm-group-co-ltds-hkg1099-low-pe-no-reason-for-excitem","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["91348","LU1115378108.SGD","BK1197","01099","BK1500","BK1515","LU0640798160.USD"],"gpt_icon":0},{"id":"2611104595","title":"Sinopharm Group  Stock Rallies 0.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2611104595","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611104595?lang=en_us&edition=fundamental","pubTime":"2026-02-16 16:33","pubTimestamp":1771230780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.8% higher to 21.48 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 26705.94.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 0.8% below its 52-week high of HK$21.66, which the company reached Nov. 14.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.6%.Trading volume totaled 1.7 million shares, compared to the 50-day average of 4.8 million shares.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","LU1115378108.SGD","01099","BK1197","BK1500","SHTDY","LU0640798160.USD","BK1515"],"gpt_icon":0},{"id":"1114235970","title":"CSPC PHARMA's Long-Acting GLP-1/GIP Dual Agonist Receives FDA Clearance for US Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1114235970","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114235970?lang=en_us&edition=fundamental","pubTime":"2026-02-16 13:40","pubTimestamp":1771220435,"startTime":"0","endTime":"0","summary":"CSPC PHARMA has announced that its long-acting injection SYH2082, a dual GLP-1/GIP receptor agonist, has received approval from the U.S. Food and Drug Administration to commence clinical trials in...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314109678.HKD","LU1328277881.USD","LU0067412154.USD","LU1993786604.SGD","LU1152091168.USD","LU1226288253.USD","BK4144","IE0008368742.USD","LU1226287792.SGD","IE0008369823.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU0140636845.USD","LU0880133367.SGD","BK1191","LU1960683339.HKD","BK1515","IE00B543WZ88.USD","LU0326950275.SGD","LU1226287529.USD","IE00BZ08YS42.EUR","LU1008478684.HKD","SG9999004220.SGD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1813983027.USD","LU1807302812.USD","GLP","BK4590","BK1521","LU2039709279.SGD","01093","IE00BZ08YT58.USD","LU1951186391.HKD","LU0315179316.USD","LU0072913022.USD","LU1226287875.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2611528105","title":"BRIEF-CSPC Pharmaceutical Obtains FDA Approval For SYH2082 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2611528105","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611528105?lang=en_us&edition=fundamental","pubTime":"2026-02-16 13:39","pubTimestamp":1771220376,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Obtains FDA Approval For SYH2082 Clinical TrialFeb 16 (Reuters) - CSPC Pharmaceutical Group Ltd 1093.HK:OBTAINS FDA APPROVAL FOR SYH2082 CLINICAL TRIALFurther company coverage: 1093.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nFWN3ZB06H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1960683339.HKD","LU1226287529.USD","LU0072913022.USD","IE0008368742.USD","LU1807302812.USD","LU2039709279.SGD","LU1993786604.SGD","SG9999004220.SGD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1226287792.SGD","LU0314109678.HKD","IE0008369823.USD","IE00B031HY20.USD","LU1008478684.HKD","LU1226288170.HKD","LU1813983027.USD","LU0326950275.SGD","IE00B543WZ88.USD","BK1191","LU1328277881.USD","BK1521","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","01093","BK1515","IE00B5MMRT66.SGD","LU0140636845.USD","LU0315179316.USD","LU0067412154.USD","LU0880133367.SGD","LU1152091168.USD","HK0000165453.HKD","LU1226287875.USD","LU1951186391.HKD","LU1226288253.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":90,"code":"91000000","status":"200"}]}}